Skip to main content
Clinical Trials/IRCT20161026030510N2
IRCT20161026030510N2RecruitingPhase 2

Investigation of Deep Brain Stimulation of Nucleus Accumbens for Treatment-Refractory Obsessive-Compulsive Disorder

Iran University of Medical Sciences0 sites5 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
5

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • •Age: 16-65
  • •Diagnosis and Severity: Sever and chronic OCD for at least 5 years, Yale-Brown scale at least 25, Hamilton scale at least 17, IQ more than 85
  • •Treatment refractoriness: Not response for SSRI for 12 weeks, clomipramine 12 weeks, atypical antipsychotics for 6 weeks and CBT for 16 seasons

Exclusion Criteria

  • •Psychotic disorders, bipolar disorder, autism disorder, substance abuse, epilepsy, dementia, Parkinson's disease and pregnancy

Investigators

Similar Trials